Home / News / Product News
New Arrival: Urocap-D, A combined effort to treat BPH
Benign Prostatic Hyperplasia (BPH) affects nearly 50% of men over 50 years old worldwide. Combination of Tamsulosin Hydrochloride and Dutasteride improve symptoms in patients with BPH. Dutasteride, a dual 5 alpha-reductase inhibitor (5 ARI) and Tamsulosin Hydrochloride, an antagonist of alpha1 A-adrenoreceptors. Treatment of BPH with Tamsulosin and Dutasteride results in an improvement in urine flow rate and reduction in symptoms of BPH. This combined effect provides synergistic effect rather than monotherapy. Ibn Sina Pharma offers Urocap-D with new technology of uniform two type of pellets. This technology is first time in Bangladesh and contains excellent uniformity in dosage form, drug release, absorption and action. Simple Once daily dosing makes it very comfortable to old patients.